Companies
PharmaLex
European consultancies (like NDA Group and PharmaLex) possess deep expertise in managing the intricate interplay between the centralized EMA procedures and national-level pricing and reimbursement negotiations.
- Country
- Germany
Commercial
Global Reach
Coverage
| CN | EU | IN | US | |
|---|---|---|---|---|
| market-access-commercial | ✓ | ✓ | ✓ | ✓ |
| regulatory-legal | ✓ | ✓ | ✓ | ✓ |
Regulatorsfdaemanmpa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| CMC regulatory consulting (BLA/MAA) | regulatory-legal | Low | → |
| Multi-jurisdictional bio-compliance (FDA+EMA+NMPA+PMDA) | market-access-commercial | Low | → |
Compiled by BIOECON from primary sources.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.